Ways to fit a PK model with some data below the quantification limit

被引:884
|
作者
Beal, SL [1 ]
机构
[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
关键词
model fitting; quantification limit; censored data;
D O I
10.1023/A:1012299115260
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmacokinetic data consist of drug concentration measurements, as well as reports of some measured concentrations being below the quantification limit of the assay (BQL). A pharmacokinetic model may befit to these data, and for this purpose, them BQL observations must be either discarded or handled in a special way. In this paper, seven methods,for dealing with BQL observations are evaluated. Both single-subject and population data are simulated from a one-compartment model. A moderate amount of data is simulated for each individual. The actual cv of concentration measurements at the quantification limit is assumed to be no greater than 20%, in accord with the FDA Guidance, The results of this paper should be interpreted in this context. The methods include handling BQL observations as fixed-point censored observations, i.e., by using the likelihoods that these observations are in fact BQL. This method is shown to have some overall statistical advantage. However, the gain in using this method over that of simply discarding the BQL observations is not always much, and this is especially so when the frequency of BQL observations is small. Some simple methods entailing (i) replacing one or more BQL observations with the value 0, or (ii) replacing them with the value QL/2, where QL is the quantification limit, are also included. The first of these two approaches should not be used. With population data, use of the second approach can result in some noticeably improved estimation of the typical value of a parameter, but then there is also marked degradation in the estimation of the population variance of the parameter.
引用
收藏
页码:481 / 504
页数:24
相关论文
共 50 条
  • [1] Ways to Fit a PK Model with Some Data Below the Quantification Limit
    Stuart L. Beal
    Journal of Pharmacokinetics and Pharmacodynamics, 2001, 28 : 481 - 504
  • [4] A BAYESIAN APPROACH FOR PK/PD MODELING WITH PD DATA BELOW LIMIT OF QUANTIFICATION
    Zhou, Huafeng
    Hartford, Alan
    Tsai, Kuenhi
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2012, 22 (06) : 1220 - 1243
  • [5] Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data
    Yang, Shuying
    Roger, James
    PHARMACEUTICAL STATISTICS, 2010, 9 (04) : 313 - 330
  • [6] Impact of censoring data below an arbitrary quantification limit on structural model misspecification
    Byon, Wonkyung
    Fletcher, Courtney V.
    Brundage, Richard C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2008, 35 (01) : 101 - 116
  • [7] Impact of censoring data below an arbitrary quantification limit on structural model misspecification
    Wonkyung Byon
    Courtney V. Fletcher
    Richard C. Brundage
    Journal of Pharmacokinetics and Pharmacodynamics, 2008, 35 : 101 - 116
  • [8] Handling Data Below the Limit of Quantification in Mixed Effect Models
    Martin Bergstrand
    Mats O. Karlsson
    The AAPS Journal, 2009, 11 : 371 - 380
  • [9] Handling Data Below the Limit of Quantification in Mixed Effect Models
    Bergstrand, Martin
    Karlsson, Mats O.
    AAPS JOURNAL, 2009, 11 (02): : 371 - 380
  • [10] Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses
    Keizer, Ron J.
    Jansen, Robert S.
    Rosing, Hilde
    Thijssen, Bas
    Beijnen, Jos H.
    Schellens, Jan H. M.
    Huitema, Alwin D. R.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2015, 3 (02): : 1 - 15